Yingying Zhang

Mrs. Yingying Zhang


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 January 2015 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
PDF file
LQLili Qiao
Lili Qiao
NLNing Liang
Ning Liang
YZYingying Zhang
Yingying Zhang
JXJian Xie
Jian Xie
FLFengjun Liu
Fengjun Liu
YTYuan Tian
Yuan Tian
Vasculogenic mimicry (VM) is a brand‐new tumour vascular paradigm independent of angiogenesis that describes the specific capacity of aggressive cancer cells to form vessel‐like networks that provide adequate blood supply for tumour growth. A variety of molecule mechanisms and signal pathways participate in VM induction. Additionally, cancer stem cell and epithelial‐mesenchymal transitions are also shown to be implicated in VM formation. As a unique perfusion way, VM is associated with tumour invasion, metastasis and poor cancer patient prognosis. Due to VM's important effects on tumour progression, more VM‐related strategies are being utilized for anticancer treatment. Here, with regard to the above aspects, we make a review of advanced research on VM in cancer.

29 March 2016 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
PDF file
QLQiqi Liu
Qiqi Liu
LQLili Qiao
Lili Qiao
NLNing Liang
Ning Liang
JXJian Xie
Jian Xie
JZJingxin Zhang
Jingxin Zhang
YZYingying Zhang
Yingying Zhang
Vasculogenic mimicry (VM) is a vascular‐like structure which can mimic the embryonic vascular network pattern to nourish the tumour tissue. As a unique perfusion way, VM is correlated with tumour progression, invasion, metastasis and lower 5‐year survival rate. Notably, epithelial‐mesenchymal transition (EMT) regulators and EMT‐related transcription factors are highly up‐regulated in VM‐forming tumour cells, which demonstrated that EMT may play a crucial role in VM formation. Therefore, the up‐regulation of EMT‐associated adhesion molecules and other factors can also make a contribution in VM‐forming process. Depending on these discoveries, VM and EMT can be utilized as therapeutic target strategies for anticancer therapy. The purpose of this article is to explore the advance research in the relationship of EMT and VM and their corresponding mechanisms in tumorigenesis effect.

14 November 2017 in Molecular and Clinical Oncology
Verified
Journal Article
Closed access
PDF file
XTXiufang Tian
Xiufang Tian
KLKun Liu
Kun Liu
YHYong Hou
Yong Hou
JCJian Cheng
Jian Cheng
YZYingying Zhang
Yingying Zhang
Proton beam therapy (PBT) has been increasingly used in a variety of cancers due to its excellent physical properties and superior dosimetric parameters. PBT may improve patient survival by improving the local tumor treatment rate while reducing injury to normal organs, which may result in fewer radiation‑induced adverse effects. However, the significant cost of establishing and maintaining proton facilities cannot be overlooked. In addition, there has been significant controversy regarding routine application of this treatment in certain types of cancer. The challenges of PBT in the future mainly include the lack of basic clinical trials, unclear biological effects, immature imaging technology and miniaturization of imaging guidance. Overcoming these limitations may promote the rapid development of PBT. We herein provide an overview of the existing literature on the efficacy and toxicity of common oncological applications of proton beam therapy.

27 December 2013 in Journal of Cancer Research and Clinical Oncology
Verified
Journal Article
Closed access
PDF file
CXC. P. Xu
C. P. Xu
XXX. J. Xue
X. J. Xue
NLN. Liang
N. Liang
DXD. G. Xu
D. G. Xu
FLF. J. Liu
F. J. Liu
YZYingying Zhang
Yingying Zhang

30 August 2016
Verified
Journal Article
Closed access
JZJingxin Zhang
Jingxin Zhang
LQLili Qiao
Lili Qiao
NLNing Liang
Ning Liang
JXJian Xie
Jian Xie
HLHui Luo
Hui Luo
YZYingying Zhang
Yingying Zhang

10 June 2023 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
MZMeng-Qi Zhang
Meng-Qi Zhang
KSKe-Xin Sun
Ke-Xin Sun
XGXu Guo
Xu Guo
YCYing-Ying Chen
Ying-Ying Chen
CFCai-Yun Feng
Cai-Yun Feng
CLChao Liu
Chao Liu